Dr Agarwals Health Care Ratios

Dr Agarwals Health Care Ltd Ratios

The Dr Agarwals Health Care Ltd Ratios page provides a complete fundamental analysis of Dr Agarwals Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Dr Agarwals Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Dr Agarwals Health Care Ltd (NSE: AGARWALEYE, BSE: 544350) is currently trading at ₹445.10, with a market capitalization of ₹140.84B. As a major player in the Health services sector and Medical/Nursing services industry, Dr Agarwals Health Care Ltd remains a key stock for fundamental analysis using Dr Agarwals Health Care Ltd Ratios.

Dr Agarwals Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Dr Agarwals Health Care Ltd P/E ratio currently stands at 160.55, making it one of the most tracked metrics in Dr Agarwals Health Care Ltd Ratios.

Historically, the Dr Agarwals Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 160.55
• 2023: 0
• 2022: 0
• 2021: 0

The rising Dr Agarwals Health Care Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Dr Agarwals Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.56.

Historical P/B trend:

• 2024: 7.56
• 2023: 0
• 2022: 0
• 2021: 0

Dr Agarwals Health Care Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Dr Agarwals Health Care Ltd P/S ratio currently stands at 7.83, an important part of Dr Agarwals Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 7.83
• 2023: 0
• 2022: 0
• 2021: 0

The rising Dr Agarwals Health Care Ltd P/S ratio indicates improved revenue valuation by investors.

Dr Agarwals Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Dr Agarwals Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 40.43.

Historical Dr Agarwals Health Care Ltd Price to Cash Flow Ratio:

• 2024: 40.43
• 2023: 0
• 2022: 0
• 2021: 0

The rising Dr Agarwals Health Care Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Dr Agarwals Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Dr Agarwals Health Care Ltd EV currently stands at ₹138.99B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 138.99B
• 2023: 0
• 2022: 0
• 2021: 0

Dr Agarwals Health Care Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Dr Agarwals Health Care Ltd EV/EBITDA ratio is currently 29.63, a key metric in Dr Agarwals Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 29.63
• 2023: 0
• 2022: 0
• 2021: 0

Higher Dr Agarwals Health Care Ltd EV/EBITDA suggests premium valuation.

Dr Agarwals Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Dr Agarwals Health Care Ltd D/E ratio is currently 0.51, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.51
• 2023: 0.72
• 2022: 1.36
• 2021: 2.98

Dr Agarwals Health Care Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Dr Agarwals Health Care Ltd ROE currently stands at 5.21%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 5.21
• 2023: 8.44
• 2022: 22.35
• 2021: 0

Declining ROE indicates pressure on profitability.

Dr Agarwals Health Care Ltd Ratios Analysis Summary

The Dr Agarwals Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Dr Agarwals Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Dr Agarwals Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.